{"id":164944,"date":"2023-01-18T00:35:58","date_gmt":"2023-01-18T05:35:58","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/aim-immunotech-enters-into-pancreatic-cancer-clinical-research-agreements-with-astrazeneca-and-erasmus-medical-center\/"},"modified":"2024-08-18T11:45:07","modified_gmt":"2024-08-18T15:45:07","slug":"aim-immunotech-enters-into-pancreatic-cancer-clinical-research-agreements-with-astrazeneca-and-erasmus-medical-center","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/aim-immunotech-enters-into-pancreatic-cancer-clinical-research-agreements-with-astrazeneca-and-erasmus-medical-center.php","title":{"rendered":"AIM ImmunoTech Enters into Pancreatic Cancer Clinical Research Agreements with AstraZeneca and Erasmus Medical Center"},"content":{"rendered":"<p><![CDATA[Research collaboration will evaluate the potential of AIM\u2019s Ampligen\u00ae (rintatolimod) in combination with AstraZeneca\u2019s Imfinzi (durvalumab) for the treatment of pancreatic cancer Research collaboration will evaluate the potential of AIM\u2019s Ampligen\u00ae (rintatolimod) in combination with AstraZeneca\u2019s Imfinzi (durvalumab) for the treatment of pancreatic cancer]]><\/p>\n<p>Go here to see the original:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2023\/01\/17\/2590008\/0\/en\/AIM-ImmunoTech-Enters-into-Pancreatic-Cancer-Clinical-Research-Agreements-with-AstraZeneca-and-Erasmus-Medical-Center.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"AIM ImmunoTech Enters into Pancreatic Cancer Clinical Research Agreements with AstraZeneca and Erasmus Medical Center\">AIM ImmunoTech Enters into Pancreatic Cancer Clinical Research Agreements with AstraZeneca and Erasmus Medical Center<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Go here to see the original: AIM ImmunoTech Enters into Pancreatic Cancer Clinical Research Agreements with AstraZeneca and Erasmus Medical Center <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/aim-immunotech-enters-into-pancreatic-cancer-clinical-research-agreements-with-astrazeneca-and-erasmus-medical-center.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-164944","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/164944"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=164944"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/164944\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=164944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=164944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=164944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}